Dr. Nader Sanai, MD
Claim this profileSt. Joseph's Hospital and Medical Center
Area of expertise
Glioblastoma
Nader Sanai, MD has run 11 trials for Glioblastoma. Some of their research focus areas include:
Brain Tumor
Nader Sanai, MD has run 10 trials for Brain Tumor. Some of their research focus areas include:
Affiliated Hospitals
St. Joseph's Hospital And Medical Center
Ivy Brain Tumor Center
Clinical Trials Nader Sanai, MD is currently running
Abemaciclib
for Meningioma
This study is being done to learn about how an investigational drug called abemaciclib works in treating patients with a newly-diagnosed grade 3 meningioma. Abemaciclib is a drug that is approved by the FDA, but not for brain tumors. Participants who consent to the trial will have surgical tissue collected from the planned surgical resection and tested. If the tissue shows positive results for RB cells and participants are qualified, they will be enrolled and receive study treatment two to five weeks after completing standard-of-care radiation therapy. This is a randomized clinical trial which means that participants will be randomly assigned to a treatment based on chance, like a flip of a coin. Neither the participant nor the researcher chooses the assigned group. Randomization will help the researchers study how the drug works by comparing the difference between the study drug and the placebo and how they work in treating brain tumors. This is a double-blinded study, which means that neither the participant nor the study team will know which treatment the participant is receiving.
Recruiting
0 awards
Phase 2
12 criteria
BDTX-1535
for Brain Tumor
This study will administer the investigational drug, BDTX-1535 to eligible patients with recurrent high-grade glioma (HGG) and newly-diagnosed glioblastoma (nGBM). BDTX-1535 was designed to block a growth signal important to some cancers. BDTX-1535 is being tested in this study to see if it can be given safely to people who have tumors that can be dependent on that growth signal because of changes in a protein called EGFR. These gene changes are called amplifications, mutations, fusions or alterations and are found only in the tumors. The study design includes a Phase 0 component with PK/PD-trigger for participant enrollment into an Expansion Phase 1 component. The primary objective of the Phase 0 component is to evaluate the PK endpoints of BDTX-1535. The primary objective of the Phase 1 component is to establish the safe dose of BDTX-1535 to be used in participants with a specified treatment regimen, three of which include standard of care radiotherapy for nGBM participants.
Recruiting
1 award
Phase < 1
6 criteria
More about Nader Sanai, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 7 Active Clinical Trials
Treatments Nader Sanai, MD has experience with
- Abemaciclib
- Radiation Therapy
- Ribociclib
- SONALA-001 And Exablate 4000 Type 2
- MR-Guided Focused Ultrasound Device (MRgFUS)
- SONALA-001(ALA) And MR-Guided Focused Ultrasound Device (MRgFUS)
Breakdown of trials Nader Sanai, MD has run
Glioblastoma
Brain Tumor
Malignant Glioma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nader Sanai, MD specialize in?
Nader Sanai, MD focuses on Glioblastoma and Brain Tumor. In particular, much of their work with Glioblastoma has involved RB patients, or patients who are IDH positive.
Is Nader Sanai, MD currently recruiting for clinical trials?
Yes, Nader Sanai, MD is currently recruiting for 7 clinical trials in Phoenix Arizona. If you're interested in participating, you should apply.
Are there any treatments that Nader Sanai, MD has studied deeply?
Yes, Nader Sanai, MD has studied treatments such as Abemaciclib, Radiation therapy, Ribociclib.
What is the best way to schedule an appointment with Nader Sanai, MD?
Apply for one of the trials that Nader Sanai, MD is conducting.
What is the office address of Nader Sanai, MD?
The office of Nader Sanai, MD is located at: St. Joseph's Hospital and Medical Center, Phoenix, Arizona 85013 United States. This is the address for their practice at the St. Joseph's Hospital and Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.